12:00 AM
Aug 31, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Loramyc miconazole regulatory update

BioAlliance said Loramyc miconazole was approved in Switzerland to treat oropharyngeal candidiasis in immunocompromised patients. Earlier this month, FDA accepted an NDA for...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >